Atlas Trials

Hereditary Angioedema Types I and II

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hereditary Angioedema Types I and II

RecordFirmDate
Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (NCT05047185)Pharvaris Netherlands B.V.2022-04-19
Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (NCT04618211)Pharvaris Netherlands B.V.2021-02-03
A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema (NCT01912456)CSL Behring2014-01-01
Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema (NCT01832896)NYU Langone Health2013-08-01
A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor (NCT01760343)CSL Behring2013-01-01
Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert (NCT01467947)CSL Behring2011-11-01

Track Hereditary Angioedema Types I and II automatically

Every clearance here is in the API, with alerts when new ones post.